A randomised controlled trial of a computerised clinical decision support system for the management of psychiatric disorder in primary care.

Completed

• Conditions: Schizophrenia and other psychoses; Mental and Behavioural Disorders; Mental disorder, not otherwise specified

• Registration Number: ISRCTN57116180
• Lead Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 762

Inclusion Criteria

1. Five general practices in Bristol and Cardiff participated in the study.
2. Eligible subjects were consecutive general practitioner (GP) attenders who were aged 16 years and over who completed the general health questionnaire (GHQ-12).
3. Subjects who had a positive GHQ score (i.e. >3) and who achieved a score of 12 or more on the CIS-R (Computerised Interview Schedule [Reduced]) were randomised.

Exclusion Criteria

1. A previous diagnosis of a psychotic illness
2. A mental handicap or cognitive impairment
3. Language or literacy difficulties
4. A severe or terminal physical illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
12-item General Health Questionnaire (GHQ12)<br><br>Outcome was assessed at 6 weeks and 6 months. The subjects were sent the questionnaires by post and were reminded by telephone if they did not respond.

Secondary Outcome Measures

Name	Time	Method
1. Quality of life assessed with 6 questions<br>2. Satisfaction with treatment assessed with 1 question: If a friend were in need of similar help from a general practitioner would you recommend your GP to him/her? <br>3. Number of consultations in primary care assessed both by asking the subjects, and also by recording the number of consultations in the primary care notes of the subjects<br>4. In 2 of the practices we recorded the psychotropic medication prescriptions for all those in the trial.